Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin

NCT01525823 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: BMS-754807 (IGR-IR/IR Inhibitor)
DRUG: Metformin

Sponsor

Bristol-Myers Squibb